Maclean, thanks for the great article on IKEA. I have always wondered how IKEA offers such wide variety of products at such low costs, and that too in any location worldwide. This article has been great in understanding their focus on cost efficiency which drives the business model. I am wondering how the private Dutch company achieved such a scale and why other players could not succeed (assuming they could have also used cost efficiency measures).
Great post, Steven. I was infact discussing HBS business and operating models with a friend a few months ago. One question I have is how will the increasing focus on the online learning models change the business models going forward. Wondering if you know about the impact on other schools who have been selling online courses for some time now.
Great post. I really like how Iora Health is creating a difference in the healthcare industry. I have 2 questions:
1. As Kbouks also pointed out, how sustainable is the model in terms of attracting the top talent, esp. given that human capital is one of the most critical resources in ensuring patient-centered service?
2. Why is this approach so new? Why have other players not been able to do that? And how is Iora addressing those concerns to be able to be successful here?
Bass, thanks for the great article on how Emirates is running an efficient business model well aligned to its operating model. I am actually curious to know how have they responded (and / or plan to respond) to great competition especially from European airlines eg. Lufthansa. The reason I ask this question is because I mostly have seen Emirates and Lufthansa as the first two options while travelling to and from US, Europe, Asia and Africa which makes me believe even Lufthansa is trying to make it big. Further, it would be great to know how Emirates manage to keep its costs so low despite the superior travel experience they provide.
Hey John – thanks for bringing up that point. It caught my attention as well as to why the company is doing the IPO. The company is not issuing any more shares actually. It is indeed an offer for sale. Nonetheless, it is important to note that Dr. Lal’s IPO is the first of its kind in India. This will hopefully pave the path for many more successful IPOs of specialty chains in India, which is especially important in the context of growing healthcare spending and growing trend of specialty chains not just in diagnostics but in diabetes, ophthalmology, etc. as well.
Thanks for providing a summarized view of Aravind Eye Care, Abhilasha. I have always been intrigued by the idea of providing affordable, high-quality healthcare. One concern I have with this model though is how to ensure high quality in such an intense environment where productivity has to be maximized. I am not sure if I would like to be operated on (esp. on my eye) by doctors and nurses who have been in back-to-back surgeries for many hours.
Just curious if you have any perspective on how Aravind takes care of this.